Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 67501-67550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06207279
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
N/ARecruiting
240 participants
Started: Sep 28, 2023 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05952037
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
PHASE2Recruiting
105 participants
Started: Sep 28, 2023 · Completed: Aug 31, 2028
3 conditions1 sponsor72 locations
NCT06017687
Data Collection and Evaluation of OptiBP Under Investigational Use
NARecruiting
500,000 participants
Started: Sep 28, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05903066
TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)
N/ARecruiting
210 participants
Started: Sep 28, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor18 locations
NCT05818644
Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
N/AEnrolling by invitation
400 participants
Started: Sep 28, 2023 · Completed: Dec 31, 2025
4 conditions36 sponsors1 location
NCT05997602
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
PHASE2Recruiting
56 participants
Started: Sep 28, 2023 · Completed: May 14, 2027
2 conditions1 sponsor11 locations
NCT05691491
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
PHASE1/PHASE2Recruiting
58 participants
Started: Sep 28, 2023 · Completed: Mar 1, 2027
7 conditions1 sponsor23 locations
NCT06114004
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)
PHASE2Recruiting
88 participants
Started: Sep 28, 2023 · Completed: May 31, 2026
1 condition1 sponsor11 locations
NCT06111482
Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments.
NARecruiting
50 participants
Started: Sep 28, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT04367766
Management of the Fresh Extraction Socket in the Aesthetic Area
NARecruiting
60 participants
Started: Sep 27, 2023 · Completed: Aug 31, 2026
4 conditions1 sponsor1 location
NCT06056752
QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
PHASE1Recruiting
10 participants
Started: Sep 27, 2023 · Completed: Jul 3, 2026
1 condition1 sponsor1 location
NCT05794165
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
PHASE2Enrolling by invitation
314 participants
Started: Sep 27, 2023 · Completed: Mar 31, 2027
3 conditions2 sponsors4 locations
NCT05813093
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
NARecruiting
88 participants
Started: Sep 27, 2023 · Completed: Jul 7, 2025
1 condition1 sponsor1 location
NCT06068036
Telehealth Intervention Involving HEARTS Technical Package and Activity Monitor to Promote Physical Activity Post-stroke
NARecruiting
24 participants
Started: Sep 27, 2023 · Completed: Jul 31, 2025
1 condition5 sponsors1 location
NCT06065540
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
PHASE3Active, not recruiting
2,734 participants
Started: Sep 27, 2023 · Completed: Jan 5, 2026
1 condition1 sponsor354 locations
NCT06043011
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
N/ARecruiting
2,950 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2033
6 conditions1 sponsor1 location
NCT05894694
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
PHASE4Recruiting
320 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05953259
RCT to Evaluate STERN FIX Device as a Sternal Stabilization System in Patients After Sternotomy
NAActive, not recruiting
90 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors5 locations
NCT06303401
Comparison of Thrust Manipulation of Sacroiliac Joint and Pelvic Stabilization Exercises in Post Partum Low Back Pain
NARecruiting
44 participants
Started: Sep 27, 2023 · Completed: Aug 30, 2024
1 condition1 sponsor1 location
NCT06066346
A Study of Talquetamab for People with Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
PHASE2Recruiting
17 participants
Started: Sep 27, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors7 locations
NCT06186024
A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX
NARecruiting
36 participants
Started: Sep 27, 2023 · Completed: Jan 30, 2025
3 conditions1 sponsor1 location
NCT06065787
NeuroGlove Anxiety and Depression Study
NARecruiting
10 participants
Started: Sep 27, 2023 · Completed: Nov 1, 2024
4 conditions1 sponsor1 location
NCT05467072
PMCFU of an Annular Closure System
N/ARecruiting
250 participants
Started: Sep 27, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05967351
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
PHASE3Enrolling by invitation
400 participants
Started: Sep 27, 2023 · Completed: Nov 30, 2030
1 condition2 sponsors37 locations
NCT05988333
Psychoeducational Intervention for Families With a Member Affected by Major Depression
NARecruiting
384 participants
Started: Sep 27, 2023 · Completed: Sep 30, 2026
1 condition24 sponsors1 location
NCT06320353
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
PHASE3Active, not recruiting
266 participants
Started: Sep 27, 2023 · Completed: Jan 31, 2026
1 condition4 sponsors36 locations
NCT05899595
Effects of a Personalized Physical Training to Reduce Fatigue
NARecruiting
130 participants
Started: Sep 27, 2023 · Completed: Nov 8, 2027
1 condition2 sponsors1 location
NCT06034197
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
EARLY_PHASE1Recruiting
15 participants
Started: Sep 27, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05636618
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors
PHASE1/PHASE2Recruiting
260 participants
Started: Sep 27, 2023 · Completed: Dec 26, 2029
6 conditions1 sponsor15 locations
NCT06076291
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
PHASE1Active, not recruiting
122 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT05717725
Pulsed-field Ablation Vs. Sham Ablation to Treat AF
PHASE3Recruiting
60 participants
Started: Sep 27, 2023 · Completed: Feb 28, 2026
1 condition4 sponsors1 location
NCT06022081
Lung Ultrasound Versus Chest Radiography for Detection of Pneumothorax
NAActive, not recruiting
60 participants
Started: Sep 27, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06344572
Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia
NARecruiting
110 participants
Started: Sep 27, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05928598
Goals for Epilepsy Clinic Visits Trial
NARecruiting
152 participants
Started: Sep 27, 2023 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT06133569
ReDirection - Self Help Program for Individuals with Sexual Interest in Children
NARecruiting
60 participants
Started: Sep 27, 2023 · Completed: Oct 10, 2024
2 conditions8 sponsors6 locations
NCT06025916
Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial
PHASE4Recruiting
1,000 participants
Started: Sep 27, 2023 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT06329908
DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
EARLY_PHASE1Recruiting
20 participants
Started: Sep 27, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05285345
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
N/ARecruiting
50 participants
Started: Sep 27, 2023 · Completed: Nov 30, 2025
1 condition3 sponsors1 location
NCT06053775
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
NAActive, not recruiting
82 participants
Started: Sep 27, 2023 · Completed: Sep 30, 2025
2 conditions2 sponsors2 locations
NCT06079112
9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer
PHASE1/PHASE2Recruiting
100 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06313918
Exercise Therapy in Mental Disorders-study
NARecruiting
50 participants
Started: Sep 27, 2023 · Completed: Sep 26, 2026
2 conditions1 sponsor1 location
NCT05971706
Ozone Application in Periodontal Treatment
NARecruiting
18 participants
Started: Sep 27, 2023 · Completed: Nov 15, 2025
1 condition1 sponsor1 location
NCT05845021
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
NARecruiting
2,000 participants
Started: Sep 27, 2023 · Completed: Jul 31, 2028
3 conditions1 sponsor1 location
NCT06292949
Clinical Study of Resistant Starch in Improving Constipation
NARecruiting
30 participants
Started: Sep 27, 2023 · Completed: Sep 25, 2024
1 condition1 sponsor1 location
NCT06374251
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
NAActive, not recruiting
10 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06051045
Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
N/ARecruiting
400 participants
Started: Sep 27, 2023 · Completed: Mar 31, 2033
1 condition1 sponsor1 location
NCT05391828
Persona MC vs PS RCT With ROSA
NARecruiting
200 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05891769
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
PHASE2/PHASE3Recruiting
100 participants
Started: Sep 27, 2023 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT06066333
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
PHASE2Recruiting
12 participants
Started: Sep 27, 2023 · Completed: Sep 27, 2026
3 conditions1 sponsor7 locations
NCT06078280
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure (BETA)
NAActive, not recruiting
13 participants
Started: Sep 27, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor1 location